The Cabinet of Ministers has canceled the dissolution of the State Service of Ukraine on Medicines and Medical Devices
The Cabinet of Ministers of Ukraine has rescinded the decision to dissolve the State Service for Medicines and Drug Control (Derzhliksluzhba). Instead, the government has decided to rename the agency the Ukrainian Pharmaceutical Agency—Ukrpharma (UFA).
According to the resolution, the territorial bodies of the State Service for Medicines and Drug Control will also be renamed as territorial bodies of the Ukrpharma Agency.
The creation of the Ukrpharma Agency as a single state regulatory body in the pharmaceutical sector is provided for by the Law on Medicines. Previously, it was planned that the reorganized State Service for Medicines and Drug Control would be merged into the new agency.
In this context, the State Expert Center (SEC) of the Ministry of Health of Ukraine was to serve as the primary source of expert knowledge, human resources, and digital solutions for the new unified regulator.
The Ukrainian Agency for Medicines is to implement state policy across a wide range of areas, including the development, market authorization, quality control, safety, and efficacy of medicines.
The UFA’s jurisdiction will also include technical regulation and market surveillance of medical devices, in vitro diagnostic medical devices, active implantable medical devices, bioimplants, and cosmetic products.
A separate area of focus for the new agency will be the circulation of narcotic drugs, psychotropic substances, their analogs, and precursors, as well as combating their illicit trafficking.
In addition, the UFA will be responsible for implementing state policy in the field of blood and blood component donation and for the operation of the blood system.
Thus, the Ukrainian Pharmaceutical Agency is set to become the sole state regulator, combining a broad range of powers in the pharmaceutical, medical, and related sectors. At the same time, the Cabinet of Ministers’ decision does not provide for the dissolution of the State Service of Ukraine on Medicines and Medical Devices, but rather its renaming and continued operation within the structure of the new agency.
This decision is enshrined in Government Resolution No. 1209 of September 23, 2026.
As a reminder, the National Anti-Corruption Bureau of Ukraine (NABU) has notified Roman Isaienko, the former head of the State Service for Medicines and Drug Control, that he is under suspicion.
The case of Roman Isaienko, the former head of the State Service for Medicines and Drug Control, who is accused of concealing assets in his financial disclosures, has been referred to court. According to the investigation, the official failed to declare a house in the Kyiv region that is registered in the name of his wife’s parents but is actually used by the family.
